GlassScriptPhysician profile
Rehana Becker
NPI 1780659797
$2,318.14
in general payments reported to CMS, 2019-2025
37 companies · $1,236 in 2025
The $1,236 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $73.38 · 2021: $73.23 · 2022: $33.18 · 2023: $39.09 · 2024: $472 · 2025: $1,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,715 · Education: $33.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,714.75 |
| Education | $33.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $409.94 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $224.46 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.81 | 2019-2025 | Jardiance |
| Abbott Laboratories | $183.52 | 2019-2025 | Proclaim, Freestyle Libre 3 |
| Dexcom, INC. | $143.52 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $104.96 | 2019-2025 | Repatha, Evenity, Otezla |
| Glaxosmithkline, LLC. | $103.15 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $81.93 | 2019-2025 | Breztri, Airsupra |
| Exact Sciences Corporation | $77.62 | 2023-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $60.59 | 2024-2025 | Korlym |
| Merck Sharp & Dohme LLC | $59.06 | 2019-2025 | Gardasil 9, Capvaxive |
| Allergan, INC. | $51.23 | 2019 | |
| Viiv Healthcare Company | $48.88 | 2025 | Apretude |
| Amneal Pharmaceuticals LLC | $43.66 | 2025 | Unithroid |
| Radius Health, INC. | $41.44 | 2025 | Tymlos |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $37.08 | 2025 | Isturisa |
| Dynavax Technologies Corporation | $36.07 | 2019-2024 | Heplisav-B |
| Medtronic, INC. | $35.53 | 2023-2024 | Vanta Adaptivestim, Intellis Adaptivestim |
| Insulet Corporation | $33.07 | 2024 | Omnipod |
| Pfizer INC. | $31.14 | 2019-2025 | |
| Biogen, INC. | $28.63 | 2025 | Leqembi |
| Phathom Pharmaceuticals, INC. | $22.87 | 2024 | Voquezna |
| Amarin Pharma, INC. | $22.62 | 2019 | |
| Xeris Pharmaceuticals, INC. | $22.51 | 2025 | Keveyis |
| Abbvie INC. | $21.37 | 2024 | |
| Itamar Medical INC | $20.76 | 2022 | |
| Tandem Diabetes Care, INC. | $18.70 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Teva Pharmaceuticals USA, INC. | $17.25 | 2020 | |
| Beta Bionics, INC. | $16.86 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Astellas Pharma US INC | $16.77 | 2021 | |
| Electromed, INC. | $15.07 | 2025 | Smartvest |
| Galderma Laboratories, L.P. | $14.29 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.24 | 2021 | |
| Globus Medical, INC. | $14.16 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $13.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rehana Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.